<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32685546</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Contribution of Enteroviruses to Acute Central Nervous System or Systemic Infections in Northern Italy (2015-2017): Is It Time to Establish a National Laboratory-Based Surveillance System?</ArticleTitle><Pagination><StartPage>9393264</StartPage><MedlinePgn>9393264</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9393264</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2020/9393264</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enteroviruses (EVs) can cause infections and outbreaks of mild to severe diseases, such as central nervous system (CNS) and systemic infections. The contribution of EVs to acute CNS/systemic infections requiring hospitalization was assessed by analysing data extracted from virology laboratory database.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Real-life data obtained from two molecular virology laboratories located in Northern Italy were retrieved from databases and analysed retrospectively. The queries used to extract the data were (i) requests for EV-RNA detection in clear cerebrospinal fluid (CSF) specimens collected from hospitalized patients with suspected acute CNS (including aseptic meningitis, encephalitis, and acute flaccid myelitis/paralysis) or systemic infections (sepsis-like illness or fever (&#x2265; 38&#xb0;C) of unknown origin), (ii) CSF samples collected from January 1st, 2015, to December 31st, 2017.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">582 requests of EV-RNA detection in CSF samples collected from as many patients of any age were recorded. EV-RNA was detected in 4.5% of the CSF samples; 92.3% of EV-positive cases were patients &lt; 15&#x2009;years, 58.3% of whom were &lt; 3 months. EVs circulated all-year-round, and the highest EV-positive rates were observed from May to August. The risk of EV infection and the relative illness ratio value among children &lt; 1 - year - old were significantly higher than those observed for older patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">EV surveillance should be carried out for all pediatric patients &lt; 15&#x2009;years and especially children less than 1 year of age with clinically suspected CNS infection/systemic infections. The implementation of a laboratory-based surveillance established for analysing the virological data provided by laboratories that routinely perform EV molecular testing may enable us to determine the impact of EVs that can cause infections requiring hospitalization.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Antonio Piralla et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piralla</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6062-2579</Identifier><AffiliationInfo><Affiliation>Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrinelli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2344-6032</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardina</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3710-0940</Identifier><AffiliationInfo><Affiliation>Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galli</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0450-4156</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binda</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4495-3183</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pariani</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5681-3455</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldanti</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3358-8969</Identifier><AffiliationInfo><Affiliation>Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="Y">Central Nervous System Viral Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="Y">Myelitis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="Y">Neuromuscular Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that there is no conflict of interest regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32685546</ArticleId><ArticleId IdType="pmc">PMC7352123</ArticleId><ArticleId IdType="doi">10.1155/2020/9393264</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dunn J. J. Enteroviruses and Parechoviruses. Microbiology Spectrum. 2016;4(3) doi: 10.1128/microbiolspec.dmih2-0006-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.dmih2-0006-2015</ArticleId><ArticleId IdType="pubmed">27337462</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilla A., Megias G., Suarez J., Ojeda E., Cabrerizo M., Arnaez J. Human parechovius and enterovirus in neonates: distinct infections with overlapping features. Early Human Development. 2015;91(8):475&#x2013;478. doi: 10.1016/j.earlhumdev.2015.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2015.05.005</ArticleId><ArticleId IdType="pubmed">26067868</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld G. H., Dalhuijsen A., Kara-Za&#xef;tri C., et al. ICARES: a real-time automated detection tool for clusters of infectious diseases in the Netherlands. BMC Infectious Diseases. 2017;17(1):p. 201. doi: 10.1186/s12879-017-2300-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2300-5</ArticleId><ArticleId IdType="pmc">PMC5345172</ArticleId><ArticleId IdType="pubmed">28279150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrinelli L., Bubba L., Galli C., et al. Epidemiology and molecular characterization of influenza viruses, human parechoviruses and enteroviruses in children up to 5 years with influenza-like illness in Northern Italy during seven consecutive winter seasons (2010-2017) The Journal of General Virology. 2017;98(11):2699&#x2013;2711. doi: 10.1099/jgv.0.000937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000937</ArticleId><ArticleId IdType="pubmed">29106347</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doornum G. J. J., Schutten M., Voermans J., Guldemeester G. J. J., Niesters H. G. M. Development and implementation of real-time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens. Journal of Medical Virology. 2007;79(12):1868&#x2013;1876. doi: 10.1002/jmv.21031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21031</ArticleId><ArticleId IdType="pubmed">17935176</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan K. M., Dean A., Soe M. M. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Reports. 2009;124(3):471&#x2013;474. doi: 10.1177/003335490912400320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/003335490912400320</ArticleId><ArticleId IdType="pmc">PMC2663701</ArticleId><ArticleId IdType="pubmed">19445426</ArticleId></ArticleIdList></Reference><Reference><Citation>Istituto Nazionale di Statistica (ISTAT)   http://www.DemoGeo-Istat.it.</Citation></Reference><Reference><Citation>Harvala H., McLeish N., Kondracka J., et al. Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in Edinburgh: HPeV type 3 identified as the most common picornavirus type. Journal of Medical Virology. 2011;83(5):889&#x2013;896. doi: 10.1002/jmv.22023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.22023</ArticleId><ArticleId IdType="pubmed">21412796</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanden S. M. G., Koopmans M. P. G., Avoort H. G. A. M. Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011. European Journal of Clinical Microbiology &amp; Infectious Diseases. 2013;32(12):1525&#x2013;1531. doi: 10.1007/s10096-013-1906-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-013-1906-9</ArticleId><ArticleId IdType="pubmed">23780695</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N., LaMonte-Fowlkes A., Oberste M. S., Pallansch M. A. Prevention Centers for Disease Control and Prevention. Enterovirus surveillance--United States, 1970-2005. MMWR Surveillance Summaries. 2006;55(8):1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Antona D., L&#xe9;v&#xea;que N., Chomel J. J., Dubrou S., L&#xe9;vy-Bruhl D., Lina B. Surveillance of enteroviruses in France, 2000-2004. European Journal of Clinical Microbiology &amp; Infectious Diseases. 2007;26(6):403&#x2013;412. doi: 10.1007/s10096-007-0306-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-007-0306-4</ArticleId><ArticleId IdType="pubmed">17534678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo M., D&#xed;az-Cerio M., Mu&#xf1;oz-Almagro C., et al. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain. Journal of Medical Virology. 2017;89(3):435&#x2013;442. doi: 10.1002/jmv.24658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24658</ArticleId><ArticleId IdType="pubmed">27505281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean N. H., Martin S. M. Implementing a network for electronic surveillance reporting from public health reference laboratories: an international perspective. Emerging Infectious Diseases. 2001;7(5):773&#x2013;779. doi: 10.3201/eid0705.010502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0705.010502</ArticleId><ArticleId IdType="pmc">PMC2631881</ArticleId><ArticleId IdType="pubmed">11747687</ArticleId></ArticleIdList></Reference><Reference><Citation>Niesters H. G., Rossen J. W., van der Avoort H., et al. Laboratory-based surveillance in the molecular era: the TYPENED model, a joint data-sharing platform for clinical and public health laboratories. Euro Surveillance. 2013;18(4):p. 20387. doi: 10.2807/ese.18.04.20387-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.18.04.20387-en</ArticleId><ArticleId IdType="pubmed">23369392</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop K. S. M., Rahamat-Langendoen J. C., van der Avoort H. G. A. M., et al. VIRO-TypeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014. Eurosurveillance. 2016;21(39) doi: 10.2807/1560-7917.es.2016.21.39.30352.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.es.2016.21.39.30352</ArticleId><ArticleId IdType="pmc">PMC5069426</ArticleId><ArticleId IdType="pubmed">27719752</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>